As CXCL1 is increasingly shown to play important roles in tumor recurrence and chemoresistance, further studies on the impact of CXCL1 expression on the breast tumor microenvironment will aid in the development of novel anti-cancer therapies to combat drug resistant tumors. This evidence concerns the gene CXCL1 and cancer.